{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,8]],"date-time":"2026-07-08T01:31:12Z","timestamp":1783474272837,"version":"3.55.0"},"reference-count":119,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2018,4,1]],"date-time":"2018-04-01T00:00:00Z","timestamp":1522540800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,4,1]],"date-time":"2020-04-01T00:00:00Z","timestamp":1585699200000},"content-version":"vor","delay-in-days":731,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","jtcvsonline.org","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Journal of Thoracic and Cardiovascular Surgery"],"published-print":{"date-parts":[[2018,4]]},"DOI":"10.1016\/j.jtcvs.2017.11.018","type":"journal-article","created":{"date-parts":[[2017,11,16]],"date-time":"2017-11-16T20:46:49Z","timestamp":1510865209000},"page":"1671-1681.e11","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":24,"title":["Cost-effectiveness analysis in cardiac surgery: A review of its concepts and methodologies"],"prefix":"10.1016","volume":"155","author":[{"given":"Bart S.","family":"Ferket","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jonathan M.","family":"Oxman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexander","family":"Iribarne","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Annetine C.","family":"Gelijns","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alan J.","family":"Moskowitz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jtcvs.2017.11.018_bib1","first-page":"e38","article-title":"Heart disease and stroke statistics\u20142016 update: a report from the American Heart Association","volume":"133","author":"Mozaffarian","year":"2016","journal-title":"Circulation"},{"key":"10.1016\/j.jtcvs.2017.11.018_bib2","doi-asserted-by":"crossref","first-page":"1005","DOI":"10.1016\/S0140-6736(06)69208-8","article-title":"Burden of valvular heart diseases: a population-based study","volume":"368","author":"Nkomo","year":"2006","journal-title":"Lancet"},{"key":"10.1016\/j.jtcvs.2017.11.018_bib3","doi-asserted-by":"crossref","first-page":"1051","DOI":"10.1016\/j.jtcvs.2012.07.065","article-title":"Surgical ablation of atrial fibrillation trends and outcomes in North America","volume":"144","author":"Ad","year":"2012","journal-title":"J Thorac Cardiovasc Surg"},{"key":"10.1016\/j.jtcvs.2017.11.018_bib4","doi-asserted-by":"crossref","first-page":"2304","DOI":"10.1016\/j.jacc.2014.03.016","article-title":"ACC\/AHA statement on cost\/value methodology in clinical practice guidelines and performance measures: a report of the American College of Cardiology\/American Heart Association Task Force on Performance Measures and Task Force on Practice Guidelines","volume":"63","author":"Anderson","year":"2014","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.jtcvs.2017.11.018_bib5","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1016\/j.jtcvs.2016.10.109","article-title":"Reengineering valve patients' postdischarge management for adapting to bundled payment models","volume":"154","author":"Koeckert","year":"2017","journal-title":"J Thorac Cardiovasc Surg"},{"key":"10.1016\/j.jtcvs.2017.11.018_bib6","doi-asserted-by":"crossref","first-page":"132s","DOI":"10.1378\/chest.08-0671","article-title":"Strategies for incorporating resource allocation and economic considerations: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (8th Edition)","volume":"133","author":"Matchar","year":"2008","journal-title":"Chest"},{"key":"10.1016\/j.jtcvs.2017.11.018_bib7","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1056\/NEJMp1612619","article-title":"Cost-effectiveness analysis 2.0","volume":"376","author":"Neumann","year":"2017","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jtcvs.2017.11.018_bib8","doi-asserted-by":"crossref","first-page":"1093","DOI":"10.1001\/jama.2016.12195","article-title":"Recommendations for conduct, methodological practices, and reporting of cost-effectiveness analyses: second panel on cost-effectiveness in health and medicine","volume":"316","author":"Sanders","year":"2016","journal-title":"JAMA"},{"key":"10.1016\/j.jtcvs.2017.11.018_bib11","doi-asserted-by":"crossref","first-page":"913","DOI":"10.1056\/NEJMp1612517","article-title":"Getting real about health care costs\u2014a broader approach to cost stewardship in medical education","volume":"376","author":"Parikh","year":"2017","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jtcvs.2017.11.018_bib12","doi-asserted-by":"crossref","first-page":"1253","DOI":"10.1056\/NEJMp0911502","article-title":"Cost consciousness in patient care\u2013what is medical education's responsibility?","volume":"362","author":"Cooke","year":"2010","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jtcvs.2017.11.018_bib13","first-page":"1","article-title":"Special report: cost-effectiveness of left-ventricular assist devices as destination therapy for end-stage heart failure","volume":"19","author":"Samson","year":"2004","journal-title":"Technol Eval Cent Assess Program Exec Summ"},{"key":"10.1016\/j.jtcvs.2017.11.018_bib14","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1017\/S0266462307070353","article-title":"Clinical and cost-effectiveness of left ventricular assist devices as destination therapy for people with end-stage heart failure: a systematic review and economic evaluation","volume":"23","author":"Clegg","year":"2007","journal-title":"Int J Technol Assess Health Care"},{"key":"10.1016\/j.jtcvs.2017.11.018_bib15","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1161\/CIRCHEARTFAILURE.111.962951","article-title":"Cost-effectiveness analysis of continuous-flow left ventricular assist devices as destination therapy","volume":"5","author":"Rogers","year":"2012","journal-title":"Circ Heart Fail"},{"key":"10.1016\/j.jtcvs.2017.11.018_bib16","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1017\/S0266462313000238","article-title":"Cost-effectiveness of continuous-flow left ventricular assist devices","volume":"29","author":"Neyt","year":"2013","journal-title":"Int J Technol Assess Health Care"},{"key":"10.1016\/j.jtcvs.2017.11.018_bib17","doi-asserted-by":"crossref","first-page":"470","DOI":"10.1161\/CIRCHEARTFAILURE.113.000807","article-title":"Comparative survival and cost-effectiveness of advanced therapies for end-stage heart failure","volume":"7","author":"Long","year":"2014","journal-title":"Circ Heart Fail"},{"key":"10.1016\/j.jtcvs.2017.11.018_bib18","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1016\/j.jchf.2016.09.008","article-title":"Cost-effectiveness of left ventricular assist devices in ambulatory patients with advanced heart failure","volume":"5","author":"Baras Shreibati","year":"2016","journal-title":"JACC Heart Fail"},{"key":"10.1016\/j.jtcvs.2017.11.018_bib19","doi-asserted-by":"crossref","first-page":"2929","DOI":"10.1093\/eurheartj\/ehi857","article-title":"Clinical and cost-effectiveness of left ventricular assist devices as a bridge to heart transplantation for people with end-stage heart failure: a systematic review and economic evaluation","volume":"27","author":"Clegg","year":"2006","journal-title":"Eur Heart J"},{"key":"10.1016\/j.jtcvs.2017.11.018_bib20","doi-asserted-by":"crossref","first-page":"1336","DOI":"10.1016\/j.healun.2006.09.011","article-title":"Cost-effectiveness of ventricular assist device use in the United Kingdom: results\u00a0from the evaluation of ventricular assist device programme in the UK (EVAD-UK)","volume":"25","author":"Sharples","year":"2006","journal-title":"J Heart Lung Transplant"},{"key":"10.1016\/j.jtcvs.2017.11.018_bib21","doi-asserted-by":"crossref","first-page":"450","DOI":"10.1016\/j.healun.2011.10.017","article-title":"Cost-effectiveness of the implantable HeartMate II left ventricular assist device for patients awaiting heart transplantation","volume":"31","author":"Moreno","year":"2012","journal-title":"J Heart Lung Transplant"},{"key":"10.1016\/j.jtcvs.2017.11.018_bib22","doi-asserted-by":"crossref","first-page":"2424","DOI":"10.1161\/CIRCULATIONAHA.112.000194","article-title":"Cost-effectiveness of ventricular assist device therapy as a bridge to transplantation compared with nonbridged cardiac recipients","volume":"127","author":"Alba","year":"2013","journal-title":"Circulation"},{"key":"10.1016\/j.jtcvs.2017.11.018_bib23","first-page":"1","volume":"17","author":"Sutcliffe","year":"2013","journal-title":"Health Technol Assess"},{"key":"10.1016\/j.jtcvs.2017.11.018_bib24","doi-asserted-by":"crossref","first-page":"338","DOI":"10.1016\/j.ijcard.2013.12.015","article-title":"Cost-effectiveness of left ventricular assist devices (LVADS) for patients with advanced heart failure: analysis of the British NHS bridge to transplant (BTT) program","volume":"171","author":"Clarke","year":"2014","journal-title":"Int J Cardiol"},{"key":"10.1016\/j.jtcvs.2017.11.018_bib25","doi-asserted-by":"crossref","first-page":"350","DOI":"10.1016\/j.healun.2014.01.003","article-title":"Comparative cost-effectiveness of the HeartWare versus HeartMate II left ventricular assist devices used in the United Kingdom National Health Service Bridge-to-Transplant Program for patients with heart failure","volume":"33","author":"Pulikottil-Jacob","year":"2014","journal-title":"J Heart Lung Transplant"},{"key":"10.1016\/j.jtcvs.2017.11.018_bib26","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1111\/j.1524-4733.2005.00045.x","article-title":"Good\u00a0research practices for cost-effectiveness analysis alongside clinical trials: the ISPOR RCT-CEA Task Force report","volume":"8","author":"Ramsey","year":"2005","journal-title":"Value Health"},{"key":"10.1016\/j.jtcvs.2017.11.018_bib27","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1586\/14737167.5.2.153","article-title":"Practical approach for using Medicare data to estimate costs for cost\u2013effectiveness analysis","volume":"5","author":"Tumeh","year":"2005","journal-title":"Expert Rev Pharmacoecon Outcomes Res"},{"key":"10.1016\/j.jtcvs.2017.11.018_bib28","series-title":"Decision Making in Health and Medicine: Integrating Evidence and Values","author":"Hunink","year":"2014"},{"key":"10.1016\/j.jtcvs.2017.11.018_bib29","series-title":"Economic Evaluation in Clinical Trials","author":"Glick","year":"2007"},{"key":"10.1016\/j.jtcvs.2017.11.018_bib30","series-title":"A Study of Charge Compression in Calculating DRG Relative Weights","author":"Dalton","year":"2007"},{"key":"10.1016\/j.jtcvs.2017.11.018_bib31","series-title":"Refining Cost to Charge Ratios for Calculating APC and MS-DRG Relative Payment Weights","author":"Dalton","year":"2008"},{"key":"10.1016\/j.jtcvs.2017.11.018_bib32","doi-asserted-by":"crossref","first-page":"1872","DOI":"10.1016\/j.jtcvs.2017.06.020","article-title":"Cost and contribution margin of transcatheter versus surgical aortic valve replacement","volume":"154","author":"McCarthy","year":"2017","journal-title":"J Thorac Cardiovasc Surg"},{"key":"10.1016\/j.jtcvs.2017.11.018_bib33","doi-asserted-by":"crossref","first-page":"1224","DOI":"10.1016\/j.jtcvs.2017.04.090","article-title":"Outcomes, readmissions, and costs in transfemoral and alterative access transcatheter aortic valve replacement in the US Medicare population","volume":"154","author":"McCarthy","year":"2017","journal-title":"J Thorac Cardiovasc Surg"},{"key":"10.1016\/j.jtcvs.2017.11.018_bib34","doi-asserted-by":"crossref","first-page":"S51","DOI":"10.1097\/MLR.0b013e31819c95aa","article-title":"Administrative and claims records as sources of health care cost data","volume":"47","author":"Riley","year":"2009","journal-title":"Med Care"},{"key":"10.1016\/j.jtcvs.2017.11.018_bib35","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1002\/clc.22341","article-title":"Hospitalization costs for acute myocardial infarction patients treated with percutaneous coronary intervention in the United States are substantially higher than Medicare payments","volume":"38","author":"Afana","year":"2015","journal-title":"Clin Cardiol"},{"key":"10.1016\/j.jtcvs.2017.11.018_bib37","doi-asserted-by":"crossref","first-page":"452","DOI":"10.1067\/mhj.2003.3","article-title":"Comparison of analytic approaches for the economic evaluation of new technologies alongside multicenter clinical trials","volume":"145","author":"Taira","year":"2003","journal-title":"Am Heart J"},{"key":"10.1016\/j.jtcvs.2017.11.018_bib38","doi-asserted-by":"crossref","first-page":"1814","DOI":"10.1111\/j.1475-6773.2012.01460.x","article-title":"What hospital inpatient services contributed the most to the 2001-2006 growth in the cost per case?","volume":"47","author":"Maeda","year":"2012","journal-title":"Health Serv Res"},{"key":"10.1016\/j.jtcvs.2017.11.018_bib39","series-title":"Tools for More Accurate Inpatient Cost Estimates With HCUP Databases, 2009. Errata added October 25, 2012. HCUP Methods Series","author":"Sun","year":"2012"},{"key":"10.1016\/j.jtcvs.2017.11.018_bib40","doi-asserted-by":"crossref","first-page":"599","DOI":"10.3111\/13696998.2014.923892","article-title":"A Canadian cost-effectiveness analysis of transcatheter mitral valve repair with the MitraClip system in high surgical risk patients with significant mitral regurgitation","volume":"17","author":"Cameron","year":"2014","journal-title":"J Med Econ"},{"key":"10.1016\/j.jtcvs.2017.11.018_bib41","doi-asserted-by":"crossref","first-page":"696","DOI":"10.3111\/13696998.2016.1157484","article-title":"MitraClip therapy in mitral regurgitation: a Markov model for the cost-effectiveness of a new therapeutic option","volume":"19","author":"Guerin","year":"2016","journal-title":"J Med Econ"},{"key":"10.1016\/j.jtcvs.2017.11.018_bib42","doi-asserted-by":"crossref","first-page":"1960","DOI":"10.1161\/01.CIR.0000143379.26342.5C","article-title":"Medical costs and quality of life 10 to 12 years after randomization to angioplasty or bypass surgery for multivessel coronary artery disease","volume":"110","author":"Hlatky","year":"2004","journal-title":"Circulation"},{"key":"10.1016\/j.jtcvs.2017.11.018_bib43","doi-asserted-by":"crossref","first-page":"820","DOI":"10.1161\/CIRCULATIONAHA.112.147488","article-title":"Cost-effectiveness of percutaneous coronary intervention with drug eluting stents versus bypass surgery for patients with diabetes mellitus and multivessel coronary artery disease: results from the FREEDOM trial","volume":"127","author":"Magnuson","year":"2013","journal-title":"Circulation"},{"key":"10.1016\/j.jtcvs.2017.11.018_bib44","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/j.jacc.2015.10.046","article-title":"Cost-effectiveness of transcatheter aortic valve replacement with a self-expanding prosthesis versus surgical aortic valve replacement","volume":"67","author":"Reynolds","year":"2016","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.jtcvs.2017.11.018_bib45","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1177\/0272989X09347016","article-title":"Comparison of 5 health-related quality-of-life indexes using item response theory analysis","volume":"30","author":"Fryback","year":"2010","journal-title":"Med Decis Making"},{"key":"10.1016\/j.jtcvs.2017.11.018_bib46","doi-asserted-by":"crossref","first-page":"1239","DOI":"10.1007\/s11136-009-9533-8","article-title":"Measuring health-related quality of life in population-based studies of coronary heart disease: comparing six generic indexes and a disease-specific proxy score","volume":"18","author":"Garster","year":"2009","journal-title":"Qual Life Res"},{"key":"10.1016\/j.jtcvs.2017.11.018_bib47","doi-asserted-by":"crossref","first-page":"410","DOI":"10.1177\/0272989X06290495","article-title":"Preference-based EQ-5D index scores for\u00a0chronic\u00a0conditions in the United States","volume":"26","author":"Sullivan","year":"2006","journal-title":"Med Decis Making"},{"key":"10.1016\/j.jtcvs.2017.11.018_bib48","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1097\/SLA.0000000000001569","article-title":"Clinical decision analysis and Markov modeling for surgeons: an introductory overview","volume":"264","author":"Hogendoorn","year":"2016","journal-title":"Ann Surg"},{"key":"10.1016\/j.jtcvs.2017.11.018_bib49","doi-asserted-by":"crossref","first-page":"322","DOI":"10.1177\/0272989X9301300409","article-title":"Markov models in medical decision making: a\u00a0practical guide","volume":"13","author":"Sonnenberg","year":"1993","journal-title":"Med Decis Making"},{"key":"10.1016\/j.jtcvs.2017.11.018_bib50","doi-asserted-by":"crossref","first-page":"621","DOI":"10.1136\/bmj.39112.480023.BE","article-title":"Cost effectiveness\u00a0analysis of minimally invasive internal thoracic artery bypass versus percutaneous revascularisation for isolated lesions of the left anterior descending artery","volume":"334","author":"Rao","year":"2007","journal-title":"BMJ"},{"key":"10.1016\/j.jtcvs.2017.11.018_bib51","doi-asserted-by":"crossref","first-page":"394","DOI":"10.1510\/icvts.2010.249482","article-title":"Cost-effectiveness of ablation surgery in patients with atrial fibrillation undergoing cardiac surgery","volume":"12","author":"van Breugel","year":"2011","journal-title":"Interact Cardiovasc Thorac Surg"},{"key":"10.1016\/j.jtcvs.2017.11.018_bib52","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1017\/S0266462309990511","article-title":"The cost-effectiveness of maze procedures using ablation techniques at the time of mitral valve surgery","volume":"25","author":"Quenneville","year":"2009","journal-title":"Int J Technol Assess Health Care"},{"key":"10.1016\/j.jtcvs.2017.11.018_bib53","doi-asserted-by":"crossref","first-page":"722","DOI":"10.1177\/0272989X12458348","article-title":"Model parameter estimation and uncertainty analysis: a report of the ISPOR-SMDM Modeling Good Research Practices Task Force Working Group-6","volume":"32","author":"Briggs","year":"2012","journal-title":"Med Decis Making"},{"key":"10.1016\/j.jtcvs.2017.11.018_bib54","doi-asserted-by":"crossref","first-page":"1810","DOI":"10.1161\/CIR.0b013e31829e8807","article-title":"2013 ACCF\/AHA guideline for the management of heart failure: executive summary: a report of the American College of Cardiology Foundation\/American Heart\u00a0Association Task Force on Practice Guidelines","volume":"128","author":"Yancy","year":"2013","journal-title":"Circulation"},{"key":"10.1016\/j.jtcvs.2017.11.018_bib55","doi-asserted-by":"crossref","first-page":"776","DOI":"10.1016\/j.jacc.2017.04.025","volume":"70","author":"Yancy","year":"2017","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.jtcvs.2017.11.018_bib56","doi-asserted-by":"crossref","first-page":"891","DOI":"10.1002\/ejhf.592","volume":"18","author":"Ponikowski","year":"2016","journal-title":"Eur J Heart Fail"},{"key":"10.1016\/j.jtcvs.2017.11.018_bib57","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1016\/j.healun.2012.09.013","article-title":"The 2013 International Society for Heart and Lung Transplantation guidelines for mechanical circulatory support: executive summary","volume":"32","author":"Feldman","year":"2013","journal-title":"J Heart Lung Transplant"},{"key":"10.1016\/j.jtcvs.2017.11.018_bib58","doi-asserted-by":"crossref","first-page":"f1363","DOI":"10.1136\/bmj.f1363","article-title":"Nice's end of life decision making scheme: impact on population health","volume":"346","author":"Collins","year":"2013","journal-title":"BMJ"},{"key":"10.1016\/j.jtcvs.2017.11.018_bib59","doi-asserted-by":"crossref","first-page":"1315","DOI":"10.1016\/j.jtcvs.2017.03.121","article-title":"The American Association for Thoracic Surgery 2016 Ethics Forum: \u201cCost-effectiveness and the ethics of left ventricular assist device therapy.\u201d","volume":"154","author":"Entwistle","year":"2017","journal-title":"J Thorac Cardiovasc Surg"},{"key":"10.1016\/j.jtcvs.2017.11.018_bib60","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1056\/NEJMoa1602954","article-title":"Intrapericardial left ventricular assist device for advanced heart failure","volume":"376","author":"Rogers","year":"2017","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jtcvs.2017.11.018_bib61","doi-asserted-by":"crossref","first-page":"440","DOI":"10.1056\/NEJMoa1610426","article-title":"A\u00a0fully magnetically levitated circulatory pump for advanced heart failure","volume":"376","author":"Mehra","year":"2017","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.jtcvs.2017.11.018_bib62","doi-asserted-by":"crossref","first-page":"1435","DOI":"10.1056\/NEJMoa012175","article-title":"Long-term use of a left ventricular assist device for end-stage heart failure","volume":"345","author":"Rose","year":"2001","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jtcvs.2017.11.018_bib63","author":"Beck"},{"key":"10.1016\/j.jtcvs.2017.11.018_bib64","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/j.jacc.2015.11.013","article-title":"The core value of cost-effectiveness analyses","volume":"67","author":"Dhruva","year":"2016","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.jtcvs.2017.11.018_bib65","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1016\/j.carrev.2015.08.011","article-title":"Cost-effectiveness of transcatheter versus surgical\u00a0management of structural heart disease","volume":"17","author":"Fanari","year":"2016","journal-title":"Cardiovasc Revasc Med"},{"key":"10.1016\/j.jtcvs.2017.11.018_bib66","doi-asserted-by":"crossref","first-page":"516","DOI":"10.1016\/j.jval.2016.04.019","article-title":"Considering cost-effectiveness in cardiology clinical guidelines: progress and prospects","volume":"19","author":"Hlatky","year":"2016","journal-title":"Value Health"},{"key":"10.1016\/j.jtcvs.2017.11.018_bib67","doi-asserted-by":"crossref","first-page":"626","DOI":"10.1161\/01.CIR.0000021408.40925.63","article-title":"Medical economics and the assessment of value in cardiovascular medicine: part II","volume":"106","author":"Mark","year":"2002","journal-title":"Circulation"},{"key":"10.1016\/j.jtcvs.2017.11.018_bib68","doi-asserted-by":"crossref","first-page":"610","DOI":"10.1016\/j.pcad.2014.03.001","article-title":"Quality, economics, and national guidelines\u00a0for transcatheter aortic valve replacement","volume":"56","author":"Pollak","year":"2014","journal-title":"Prog Cardiovasc Dis"},{"key":"10.1016\/j.jtcvs.2017.11.018_bib69","doi-asserted-by":"crossref","first-page":"702","DOI":"10.1016\/j.ejcts.2007.07.027","article-title":"A health economic evaluation of concomitant surgical ablation for atrial fibrillation","volume":"32","author":"Lamotte","year":"2007","journal-title":"Eur J Cardiothorac Surg"},{"key":"10.1016\/j.jtcvs.2017.11.018_bib70","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1053\/j.semtcvs.2009.05.001","article-title":"Assessing technological change in cardiothoracic surgery","volume":"21","author":"Iribarne","year":"2009","journal-title":"Semin Thorac Cardiovasc Surg"},{"key":"10.1016\/j.jtcvs.2017.11.018_bib71","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1016\/j.jtcvs.2015.08.106","article-title":"Minimally invasive mitral valve surgery is associated with equivalent cost and shorter hospital stay when compared with traditional sternotomy","volume":"151","author":"Atluri","year":"2016","journal-title":"J Thorac Cardiovasc Surg"},{"key":"10.1016\/j.jtcvs.2017.11.018_bib74","doi-asserted-by":"crossref","first-page":"1010","DOI":"10.1056\/NEJMp1613181","article-title":"Improving hospital incentives with better cost data","volume":"376","author":"Ederhof","year":"2017","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.jtcvs.2017.11.018_bib75","doi-asserted-by":"crossref","first-page":"e1001058","DOI":"10.1371\/journal.pmed.1001058","article-title":"Individualized cost-effectiveness analysis","volume":"8","author":"Ioannidis","year":"2011","journal-title":"PLoS Med"},{"key":"10.1016\/j.jtcvs.2017.11.018_bib76","doi-asserted-by":"crossref","first-page":"701","DOI":"10.1097\/ACM.0b013e318217cf25","article-title":"Integrating economic evaluation methods into clinical and translational science award consortium comparative effectiveness educational goals","volume":"86","author":"Iribarne","year":"2011","journal-title":"Acad Med"},{"key":"10.1016\/j.jtcvs.2017.11.018_bibE1","first-page":"145","article-title":"Perspective on the cost-effectiveness of transapical aortic valve implantation in high-risk patients: outcomes of a decision-analytic model","volume":"1","author":"Gada","year":"2012","journal-title":"Ann Cardiothorac Surg"},{"key":"10.1016\/j.jtcvs.2017.11.018_bibE2","doi-asserted-by":"crossref","first-page":"1326","DOI":"10.1016\/j.amjcard.2011.12.030","article-title":"Markov model for selection of aortic valve replacement versus transcatheter aortic valve implantation (without replacement) in high-risk patients","volume":"109","author":"Gada","year":"2012","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.jtcvs.2017.11.018_bibE3","doi-asserted-by":"crossref","DOI":"10.1136\/bmjopen-2012-001032","article-title":"A cost-utility analysis of transcatheter aortic valve implantation in Belgium: focusing on a well-defined and identifiable population","volume":"2","author":"Neyt","year":"2012","journal-title":"BMJ Open"},{"key":"10.1016\/j.jtcvs.2017.11.018_bibE4","doi-asserted-by":"crossref","first-page":"1102","DOI":"10.1161\/CIRCULATIONAHA.111.054072","article-title":"Cost-effectiveness of transcatheter aortic valve replacement compared with standard care among inoperable patients with severe aortic stenosis: results from the Placement of Aortic Transcatheter Valves (PARTNER) Trial (Cohort B)","volume":"125","author":"Reynolds","year":"2012","journal-title":"Circulation"},{"key":"10.1016\/j.jtcvs.2017.11.018_bibE5","doi-asserted-by":"crossref","first-page":"370","DOI":"10.1136\/heartjnl-2011-300444","article-title":"Cost-effectiveness of transcatheter aortic valve replacement in patients ineligible for conventional aortic valve replacement","volume":"98","author":"Watt","year":"2012","journal-title":"Heart"},{"key":"10.1016\/j.jtcvs.2017.11.018_bibE6","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1016\/j.jtcvs.2012.06.018","article-title":"Cost-effectiveness of the Edwards SAPIEN transcatheter heart valve compared with standard management and surgical aortic valve replacement in patients with severe symptomatic aortic stenosis: a Canadian perspective","volume":"146","author":"Doble","year":"2013","journal-title":"J Thorac Cardiovasc Surg"},{"key":"10.1016\/j.jtcvs.2017.11.018_bibE7","doi-asserted-by":"crossref","first-page":"566","DOI":"10.3111\/13696998.2013.770747","article-title":"Cost effectiveness of transcatheter aortic valve replacement compared to medical management in inoperable patients with severe aortic stenosis: Canadian analysis based on the partner trial cohort B findings","volume":"16","author":"Hancock-Howard","year":"2013","journal-title":"J Med Econ"},{"key":"10.1016\/j.jtcvs.2017.11.018_bibE8","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1017\/S0266462312000670","article-title":"Transcatheter aortic valve implantation for severe aortic stenosis: the cost-effectiveness case for inoperable patients in the United Kingdom","volume":"29","author":"Murphy","year":"2013","journal-title":"Int J Technol Assess Health Care"},{"key":"10.1016\/j.jtcvs.2017.11.018_bibE9","first-page":"1","article-title":"Transcatheter aortic valve implantation (TAVI) for treatment of aortic valve stenosis: an evidence update","volume":"13","author":"Sehatzadeh","year":"2013","journal-title":"Ont Health Technol Assess Ser"},{"key":"10.1016\/j.jtcvs.2017.11.018_bibE10","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1161\/CIRCOUTCOMES.113.000280","article-title":"Transcatheter aortic valve replacement in nonsurgical candidates with severe, symptomatic aortic stenosis: a cost-effectiveness analysis","volume":"6","author":"Simons","year":"2013","journal-title":"Circ Cardiovasc Qual Outcomes"},{"key":"10.1016\/j.jtcvs.2017.11.018_bibE11","doi-asserted-by":"crossref","first-page":"e000155","DOI":"10.1136\/openhrt-2014-000155","article-title":"Cost-utility of transcatheter aortic valve implantation for inoperable patients with severe aortic stenosis treated by medical management: a UK cost-utility analysis based on patient-level data from the advance study","volume":"1","author":"Brecker","year":"2014","journal-title":"Open Heart"},{"key":"10.1016\/j.jtcvs.2017.11.018_bibE12","doi-asserted-by":"crossref","first-page":"e000414","DOI":"10.1136\/openhrt-2016-000414","article-title":"Severe symptomatic aortic stenosis: medical therapy and transcatheter aortic valve implantation (TAVI)\u2014a real-world retrospective cohort analysis of outcomes and cost-effectiveness using national data","volume":"3","author":"Freeman","year":"2016","journal-title":"Open Heart"},{"key":"10.1016\/j.jtcvs.2017.11.018_bibE13","doi-asserted-by":"crossref","first-page":"2683","DOI":"10.1016\/j.jacc.2012.09.018","article-title":"Cost-effectiveness of transcatheter aortic valve replacement compared with surgical aortic valve replacement in high-risk patients with severe aortic stenosis: results of the PARTNER (Placement of Aortic Transcatheter Valves) trial (Cohort A)","volume":"60","author":"Reynolds","year":"2012","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.jtcvs.2017.11.018_bibE14","doi-asserted-by":"crossref","first-page":"914","DOI":"10.1136\/heartjnl-2013-303722","article-title":"The cost-effectiveness of transcatheter aortic valve implantation versus surgical aortic valve replacement in patients with severe aortic stenosis at high operative risk","volume":"99","author":"Fairbairn","year":"2013","journal-title":"Heart"},{"key":"10.1016\/j.jtcvs.2017.11.018_bibE15","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/j.jacc.2015.10.046","article-title":"Cost-effectiveness of transcatheter aortic valve replacement with a self-expanding prosthesis versus surgical aortic valve replacement","volume":"67","author":"Reynolds","year":"2016","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.jtcvs.2017.11.018_bibE16","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1016\/j.ijcard.2014.12.109","article-title":"Transfemoral transcatheter aortic valve replacement compared with surgical replacement in patients with severe aortic stenosis and comparable risk: cost-utility and its determinants","volume":"182","author":"Ribera","year":"2015","journal-title":"Int J Cardiol"},{"key":"10.1016\/j.jtcvs.2017.11.018_bibE17","doi-asserted-by":"crossref","first-page":"1011","DOI":"10.1080\/13696998.2016.1220949","article-title":"The economic value of intuity in aortic valve replacement","volume":"19","author":"Moore","year":"2016","journal-title":"J Med Econ"},{"key":"10.1016\/j.jtcvs.2017.11.018_bibE18","doi-asserted-by":"crossref","first-page":"1317","DOI":"10.3111\/13696998.2013.834823","article-title":"EVEREST II high risk study based UK cost-effectiveness analysis of MitraClip\u00ae in patients with severe mitral regurgitation ineligible for conventional repair\/replacement surgery","volume":"16","author":"Mealing","year":"2013","journal-title":"J Med Econ"},{"key":"10.1016\/j.jtcvs.2017.11.018_bibE19","doi-asserted-by":"crossref","first-page":"599","DOI":"10.3111\/13696998.2014.923892","article-title":"A Canadian cost-effectiveness analysis of transcatheter mitral valve repair with the MitraClip system in high surgical risk patients with significant mitral regurgitation","volume":"17","author":"Cameron","year":"2014","journal-title":"J Med Econ"},{"key":"10.1016\/j.jtcvs.2017.11.018_bibE20","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1016\/j.ijcard.2016.01.212","article-title":"Real-world cost effectiveness of MitraClip combined with medical therapy versus medical therapy alone in patients with moderate or severe mitral regurgitation","volume":"209","author":"Armeni","year":"2016","journal-title":"Int J Cardiol"},{"key":"10.1016\/j.jtcvs.2017.11.018_bibE21","first-page":"1","article-title":"Clinical outcomes and economic impact of transcatheter mitral leaflet repair in heart failure patients","volume":"20","author":"Asgar","year":"2016","journal-title":"J Med Econ"},{"key":"10.1016\/j.jtcvs.2017.11.018_bibE22","doi-asserted-by":"crossref","first-page":"696","DOI":"10.3111\/13696998.2016.1157484","article-title":"MitraClip therapy in mitral regurgitation: a Markov model for the cost-effectiveness of a new therapeutic option","volume":"19","author":"Guerin","year":"2016","journal-title":"J Med Econ"},{"key":"10.1016\/j.jtcvs.2017.11.018_bibE23","doi-asserted-by":"crossref","first-page":"702","DOI":"10.1016\/j.ejcts.2007.07.027","article-title":"A health economic evaluation of concomitant surgical ablation for atrial fibrillation","volume":"32","author":"Lamotte","year":"2007","journal-title":"Eur J Cardiothorac Surg"},{"key":"10.1016\/j.jtcvs.2017.11.018_bibE24","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1017\/S0266462309990511","article-title":"The cost-effectiveness of maze procedures using ablation techniques at the time of mitral valve surgery","volume":"25","author":"Quenneville","year":"2009","journal-title":"Int J Technol Assess Health Care"},{"key":"10.1016\/j.jtcvs.2017.11.018_bibE25","doi-asserted-by":"crossref","first-page":"394","DOI":"10.1510\/icvts.2010.249482","article-title":"Cost-effectiveness of ablation surgery in patients with atrial fibrillation\u00a0undergoing cardiac surgery","volume":"12","author":"van Breugel","year":"2011","journal-title":"Interact Cardiovasc Thorac Surg"},{"key":"10.1016\/j.jtcvs.2017.11.018_bibE26","doi-asserted-by":"crossref","first-page":"481","DOI":"10.3111\/13696998.2014.911185","article-title":"Cost-effectiveness of the convergent procedure and catheter ablation for non-paroxysmal atrial fibrillation","volume":"17","author":"Anderson","year":"2014","journal-title":"J Med Econ"},{"key":"10.1016\/j.jtcvs.2017.11.018_bibE27","doi-asserted-by":"crossref","first-page":"2870","DOI":"10.1161\/01.CIR.0000100723.50363.2C","article-title":"Randomized comparison between stenting and off-pump bypass surgery in patients referred for angioplasty","volume":"108","author":"Eefting","year":"2003","journal-title":"Circulation"},{"key":"10.1016\/j.jtcvs.2017.11.018_bibE28","doi-asserted-by":"crossref","first-page":"1960","DOI":"10.1161\/01.CIR.0000143379.26342.5C","article-title":"Medical costs and quality of life 10 to 12 years after randomization to angioplasty or bypass surgery for multivessel coronary artery disease","volume":"110","author":"Hlatky","year":"2004","journal-title":"Circulation"},{"key":"10.1016\/j.jtcvs.2017.11.018_bibE29","first-page":"259","article-title":"Off-pump coronary artery bypass surgery compared with stent implantation and on-pump bypass surgery: clinical outcome and cost-effectiveness at one year","volume":"13","author":"Nathoe","year":"2005","journal-title":"Neth Heart J"},{"key":"10.1016\/j.jtcvs.2017.11.018_bibE30","doi-asserted-by":"crossref","first-page":"1251","DOI":"10.1161\/CIRCULATIONAHA.105.570838","article-title":"Cost-effectiveness of coronary artery bypass grafts versus percutaneous coronary intervention for revascularization of high-risk patients","volume":"114","author":"Stroupe","year":"2006","journal-title":"Circulation"},{"key":"10.1016\/j.jtcvs.2017.11.018_bibE31","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1016\/j.ejcnurse.2006.04.001","article-title":"Costs, clinical outcomes, and health-related quality of life of off-pump vs. on-pump coronary bypass surgery","volume":"6","author":"Kastanioti","year":"2007","journal-title":"Eur J Cardiovasc Nurs"},{"key":"10.1016\/j.jtcvs.2017.11.018_bibE32","doi-asserted-by":"crossref","first-page":"820","DOI":"10.1161\/CIRCULATIONAHA.112.147488","article-title":"Cost-effectiveness of percutaneous coronary intervention with drug eluting stents versus bypass surgery for patients with diabetes mellitus and multivessel coronary artery disease: results from the FREEDOM trial","volume":"127","author":"Magnuson","year":"2013","journal-title":"Circulation"},{"key":"10.1016\/j.jtcvs.2017.11.018_bibE33","doi-asserted-by":"crossref","first-page":"1146","DOI":"10.1161\/CIRCULATIONAHA.114.009985","volume":"130","author":"Cohen","year":"2014","journal-title":"Circulation"},{"key":"10.1016\/j.jtcvs.2017.11.018_bibE34","doi-asserted-by":"crossref","first-page":"366","DOI":"10.1017\/S0266462314000439","article-title":"Coronary bypass surgery versus percutaneous coronary intervention: cost-effectiveness in Iran: a study in patients with multivessel coronary artery disease","volume":"30","author":"Javanbakht","year":"2014","journal-title":"Int J Technol Assess Health Care"},{"key":"10.1016\/j.jtcvs.2017.11.018_bibE35","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.jacc.2014.09.078","article-title":"Cost-effectiveness of revascularization strategies: the ASCERT study","volume":"65","author":"Zhang","year":"2015","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.jtcvs.2017.11.018_bibE36","doi-asserted-by":"crossref","first-page":"382","DOI":"10.1016\/S0002-9343(03)00296-1","article-title":"Cost-effectiveness of bypass surgery versus stenting in patients with multivessel coronary artery disease","volume":"115","author":"Yock","year":"2003","journal-title":"Am J Med"},{"key":"10.1016\/j.jtcvs.2017.11.018_bibE37","doi-asserted-by":"crossref","first-page":"624","DOI":"10.1136\/bmj.39129.442164.55","article-title":"Cost effectiveness of clinically appropriate decisions on alternative treatments for angina pectoris: prospective observational study","volume":"334","author":"Griffin","year":"2007","journal-title":"BMJ"},{"key":"10.1016\/j.jtcvs.2017.11.018_bibE38","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1007\/s10916-008-9190-4","article-title":"Assessing the economic attractiveness of coronary artery revascularization in chronic kidney disease patients","volume":"33","author":"Eisenstein","year":"2009","journal-title":"J Med Syst"},{"key":"10.1016\/j.jtcvs.2017.11.018_bibE39","doi-asserted-by":"crossref","first-page":"793","DOI":"10.1053\/j.jvca.2007.05.016","article-title":"Influence of intraoperative conversion from off-pump to on-pump coronary artery bypass grafting on costs and quality of life: a cost-effectiveness analysis","volume":"21","author":"Shiga","year":"2007","journal-title":"J Cardiothorac Vasc Anesth"},{"key":"10.1016\/j.jtcvs.2017.11.018_bibE40","doi-asserted-by":"crossref","first-page":"891","DOI":"10.1111\/j.1525-1594.2008.00647.x","article-title":"Economic evaluation of coronary artery bypass grafting surgery with and without cardiopulmonary bypass: cost-effectiveness and quality-adjusted life years in a randomized controlled trial","volume":"32","author":"Al-Ruzzeh","year":"2008","journal-title":"Artif Organs"},{"key":"10.1016\/j.jtcvs.2017.11.018_bibE41","doi-asserted-by":"crossref","first-page":"185","DOI":"10.3109\/14017431.2013.781672","article-title":"OPCAB surgery is cost-effective for elderly patients","volume":"47","author":"Houlind","year":"2013","journal-title":"Scand Cardiovasc J"},{"key":"10.1016\/j.jtcvs.2017.11.018_bibE42","doi-asserted-by":"crossref","first-page":"770","DOI":"10.1016\/j.athoracsur.2013.04.074","article-title":"On-pump versus off-pump coronary artery bypass surgery: cost-effectiveness analysis alongside a multisite trial","volume":"96","author":"Wagner","year":"2013","journal-title":"Ann Thorac Surg"},{"key":"10.1016\/j.jtcvs.2017.11.018_bibE43","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3310\/hta8160","article-title":"A\u00a0multi-centre randomised controlled trial of minimally invasive direct coronary bypass grafting versus percutaneous transluminal coronary angioplasty with stenting for proximal stenosis of the left anterior descending coronary artery","volume":"8","author":"Reeves","year":"2004","journal-title":"Health Technol Assess"},{"key":"10.1016\/j.jtcvs.2017.11.018_bibE44","doi-asserted-by":"crossref","first-page":"621","DOI":"10.1136\/bmj.39112.480023.BE","article-title":"Cost effectiveness analysis of minimally invasive internal thoracic artery bypass versus percutaneous revascularisation for isolated lesions of the left anterior descending artery","volume":"334","author":"Rao","year":"2007","journal-title":"BMJ"},{"key":"10.1016\/j.jtcvs.2017.11.018_bibE45","doi-asserted-by":"crossref","first-page":"809","DOI":"10.1016\/j.jtcvs.2007.09.042","article-title":"Is minimally invasive\u00a0harvesting of the great saphenous vein for coronary artery bypass surgery a cost-effective technique?","volume":"135","author":"Rao","year":"2008","journal-title":"J Thorac Cardiovasc Surg"},{"key":"10.1016\/j.jtcvs.2017.11.018_bibE46","doi-asserted-by":"crossref","first-page":"1174","DOI":"10.1016\/j.athoracsur.2012.01.029","article-title":"Economic evaluation of endoscopic versus open vein harvest for coronary artery bypass grafting","volume":"93","author":"Oddershede","year":"2012","journal-title":"Ann Thorac Surg"},{"key":"10.1016\/j.jtcvs.2017.11.018_bibE47","doi-asserted-by":"crossref","first-page":"2550","DOI":"10.1161\/CIRCULATIONAHA.109.912709","article-title":"Economic outcomes of treatment strategies for type 2 diabetes mellitus and coronary artery disease in the Bypass Angioplasty Revascularization Investigation 2 Diabetes Trial","volume":"120","author":"Hlatky","year":"2009","journal-title":"Circulation"},{"key":"10.1016\/j.jtcvs.2017.11.018_bibE48","doi-asserted-by":"crossref","first-page":"812","DOI":"10.7326\/M14-0845","article-title":"Models in the development of clinical practice guidelines","volume":"161","author":"Habbema","year":"2014","journal-title":"Ann Intern Med"}],"container-title":["The Journal of Thoracic and Cardiovascular Surgery"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022522317326909?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022522317326909?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,4,1]],"date-time":"2020-04-01T01:23:58Z","timestamp":1585704238000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0022522317326909"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,4]]},"references-count":119,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2018,4]]}},"alternative-id":["S0022522317326909"],"URL":"https:\/\/doi.org\/10.1016\/j.jtcvs.2017.11.018","relation":{},"ISSN":["0022-5223"],"issn-type":[{"value":"0022-5223","type":"print"}],"subject":[],"published":{"date-parts":[[2018,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Cost-effectiveness analysis in cardiac surgery: A review of its concepts and methodologies","name":"articletitle","label":"Article Title"},{"value":"The Journal of Thoracic and Cardiovascular Surgery","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jtcvs.2017.11.018","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"simple-article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 by The American Association for Thoracic Surgery","name":"copyright","label":"Copyright"}]}}